The pill times 2: what every woman with multiple sclerosis should know.
From the Department of Research & Evaluation and Southern California Permanente Medical Group, Kaiser Permanente Southern California, Pasadena; and the Neurology Department, Los Angeles Medical Center, CA.
Annette M
AM
Langer-Gould
D000014:Abnormalities, Drug-Induced; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine